| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/01/1997 | CA2188634A1 1ó,26 dihydroxy-d-homo-vitamin d3 |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148808A Anti-acne composition |
| 04/30/1997 | CN1148803A Milk antimicrobial liquid cleaning agent |
| 04/30/1997 | CN1148503A Application of noval peptidic compound in preparation of medicine |
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625067 Cyclopentane ether derivatives, processes for their production, and their pharmaceutical use |
| 04/29/1997 | US5624949 Protein kinase C inhibitors |
| 04/29/1997 | US5624673 Cosmetic or pharmaceutical composition containing a prunella extract |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/29/1997 | CA2089207C Amphoteric tricyclic compound |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/28/1997 | CA2186192A1 Topical composition containing specific flavanones |
| 04/24/1997 | WO1997014713A1 Amphiphilic complexes, method for preparing same and compositions containing such complexes |
| 04/24/1997 | WO1997014425A1 Two novel genes from psoriatic epidermis: psoriastatin type i and psoriastatin type ii |
| 04/24/1997 | WO1997014400A1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/24/1997 | CA2234968A1 Topically applied, structural cellulite treatments |
| 04/24/1997 | CA2232424A1 Cosmetic composition for the treatment of keratinous materials comprising at least a grafted silicone polymer and at least an aqueous dispersion of insoluble particles of non ionic or cationic polymer |
| 04/23/1997 | EP0769293A2 Use of at least a beta-adrenergic agonist as an antagonist of substance P |
| 04/23/1997 | EP0768888A1 Use of muramyl peptide compounds |
| 04/23/1997 | EP0768884A1 Drugs containing metronidazole or a synergistic mixture of metronidazole and clindamycin |
| 04/23/1997 | EP0768877A1 Antikeratolytic-wound healing compositions and methods for preparing and using same |
| 04/23/1997 | EP0768869A1 Factor to grow tissue ex vivo |
| 04/23/1997 | EP0768866A1 Desquamation compositions |
| 04/23/1997 | EP0703776B1 Utilization of a peptide having a lysin group and an alanine group in the terminal position for the preparation of a depigmenting composition, and depigmenting composition thus obtained |
| 04/23/1997 | EP0623123B1 Benzopyran and related LTB4-antagonists |
| 04/23/1997 | EP0495049B1 Process for the enzymatic preparation of basic fibroblast growth factor |
| 04/22/1997 | US5622982 Enzyme inhibitors; antiinflammatory agents |
| 04/22/1997 | US5622962 Prostate cancer, skin disorders, baldness |
| 04/22/1997 | US5622961 5α-reductase inhibitors |
| 04/22/1997 | US5622941 Administering the dosage form, nontoxic activated vitamin d; sustain release, side-effect reducation |
| 04/22/1997 | US5622939 Glucan preparation |
| 04/22/1997 | US5622927 Mixture containing folic acid, panthenol and/or allantoin, protein hydrolysate, lactose or dextrose, lactic acid, magnesium sulfate, sodium or ammonium chloride, and a carrier; stability |
| 04/22/1997 | US5622701 Provides monoclonal antibodies that have binding site that specifically binds to p-selectin and to e-selectin |
| 04/17/1997 | WO1997013857A1 Combination pdgf, kgf, igf and igfbp for wound healing |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013528A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/17/1997 | WO1997013520A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | WO1997013518A1 Treatment of pruritus with vitamin d and analogs thereof |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013493A1 Use of bradykinin antagonists for stimulating or inducing hair growth and/or arresting hair loss |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2231647A1 Fast drying, film forming iodine release solution |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2231273A1 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
| 04/16/1997 | EP0768380A2 Gene regulating aureobasidin sensitivity |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0767796A1 Monocyte chemotactic protein-4 |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0767658A1 Anti-acne cosmetic compositions |
| 04/16/1997 | CN1147385A Medicine liquid for burns and its prepn |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621098 Process for preparing bis-indolyl macrocycles |
| 04/15/1997 | US5621081 Polypeptide; treatment of nervous system disorders |
| 04/15/1997 | US5621012 Active compound combinations having a content of glyceryl alkyl ethers and cosmetic and dermatological formulations comprising such active compound combinations |
| 04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620965 Applying to skin a mixture of salycylic acid, penetration enhancing agent, and carrier |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/15/1997 | US5620701 Methods of treatment using di-linoleoyl-mono-gamma-linolenyl glycerol |
| 04/15/1997 | US5620692 Oat oil compositions with useful cosmetic and dermatological properties |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012876A1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 04/10/1997 | WO1997012853A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | WO1997012852A1 Semi-fluorinated alkanes and their use |
| 04/10/1997 | WO1997012601A2 Gel formulations containing growth factors |
| 04/10/1997 | WO1997012595A1 Composition for treating keratinous material, including at least one silicone-grafted polymer and at least one thickening polymer or copolymer of (meth)acrylamide or a (meth)acrylamide derivative, and uses thereof |
| 04/10/1997 | WO1997012591A1 Skin-care agent for ageing skin |
| 04/10/1997 | WO1997012521A1 Antiparasitic composition for treating and protecting pets |
| 04/10/1997 | WO1997005250A3 Receptor ligand vegf-c |
| 04/10/1997 | DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs. |
| 04/10/1997 | DE19537027A1 Hautpflegemittel für alte Haut Skin care products for old skin |
| 04/10/1997 | CA2233888A1 Dimer-selective rxr modulators and methods for their use |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids |
| 04/09/1997 | EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766569A1 Aav capsid vehicles for molecular transfer |
| 04/09/1997 | EP0766557A1 Topical compositions comprising n-acetyl-l-cysteine |
| 04/09/1997 | EP0766510A2 Use of a commiphora mukul extract as a pigmenting agent |
| 04/09/1997 | EP0675708B1 Pharmaceutical and dermocosmetic compositions containing equine colostrum |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/08/1997 | US5618925 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618840 Prevention growth of helicobacter |
| 04/08/1997 | US5618839 Retinoid-like compounds |
| 04/08/1997 | US5618805 19-nor-vitamin D compounds |
| 04/08/1997 | US5618799 Storage stability, noncaking, nonscattering, adhesion |
| 04/08/1997 | US5618557 Prophylactic treatment of allergic contact dermatitis |
| 04/08/1997 | US5618545 Skin-cosmetic composition |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/08/1997 | US5618521 Photoprotective/cosmetic compositions comprising antioxidants and filamentous bacterial extracts |
| 04/08/1997 | US5618516 Composition also containing water, thickener, emulsifier, propellant; applied as foam for maximum penetration |
| 04/03/1997 | WO1997011718A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/03/1997 | WO1997011712A1 Ribosome fraction and composition containing same |
| 04/03/1997 | CA2233138A1 Inhibitors of integrin receptors and their therapeutical uses |
| 04/02/1997 | EP0765871A1 Substituted Quinoline-2-carboxamides, their preparation and their use as prolyle-4-hydroxylase Inhibitors |